GlaxoSmithKline PLC

Activist Investor Nelson Peltz's Fund Buys Stake In Unilever: FT

GlaxoSmithKline PLC Looks To Continue To Trade Above Its Annual-High Share Price Today

Sponsored

The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing

GlaxoSmithKline PLC Looks To Continue To Trade Above Its Annual-High Share Price Today

Sponsored

The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing

Consult Your Doctor: FDA Thinks Big Pharma Might Be Intentionally Confusing You With Too Much Information

#PreMarket Primer: Thursday, December 4: Beige Book Paints Positive Picture Of U.S. Economy

Consult Your Doctor: FDA Thinks Big Pharma Might Be Intentionally Confusing You With Too Much Information

#PreMarket Primer: Thursday, December 4: Beige Book Paints Positive Picture Of U.S. Economy

#PreMarket Primer: Wednesday, May 14: Markets Surprised To Hear Bundesbank Is On Board With ECB Stimulus

Pharmaceutical Stocks For Income, Value And Growth Investors

GlaxoSmithKline PLC Recent News

AstraZeneca to Acquire Pearl Therapeutics to Gain Foothold into Lucrative Market (AZN, GSK, NVS)

Likely Winners and Losers in Obama's 2014 Budget

Calls Bought on Exelixis (EXEL)

FDA Asks Doctors To Suspend Use Of GlaxoSmithKline (GSK) Rotavirus Vaccine

XenoPort (XNPT) Shares Fall 65% After FDA Rejection

GlaxoSmithKline (GSK) Shares Rise With Upgrade